PRKN and Parkinson disease: This signaling pathway has been studied extensively in the context of neurodegeneration because mutations in human PINK1 (PARK6) (Valente et al., 2001, 2002) and Parkin (PARK2) (Kitada et al., 1998) are assumed to be causative for early onset Parkinson’s disease.